Among patients with operable, newly diagnosed brain metastases, treatment with GammaTile was associated with a greater than 50% reduction in the risk of either tumor recurrence or death compared to ...

When Casey DeSantis, the first lady of Florida, recently disclosed how the state would distribute $60 million for cancer ...

While Natera said it will seek FDA approval for Signatera based on data from IMvigor011, the readout from another ctDNA-guided de-escalation study was more nuanced.

When pembrolizumab was added to paclitaxel with or without bevacizumab in platinum-resistant ovarian cancer, significant ...

(UroToday.com) The 2025 European Society for Medical Oncology (ESMO) Annual Congress was host to a radioligand therapeutics proffered paper session. Dr. Karolien Goffin discussed the previously ...

AstraZeneca and Daiichi Sankyo are challenging Gilead Sciences for dominance in one of the toughest-to-treat breast cancers in a race for patients — and profits.

Therapeutics announced the addition of several key large cancer centers to its ongoing pivotal Phase 3 clinical study, notably ...

India’s cancer care sector, valued at Rs 1.25 lakh crore and growing 10–12% annually, is attracting significant private ...

Natera has announced positive results from the Phase III IMvigor011 clinical trial for muscle-invasive bladder cancer (MIBC).

Life Healthcare Group, a leading private healthcare provider in Southern Africa, exemplifies the profound impact of an ...

A novel combination therapy pairing a DNA-synthesis inhibitor with a targeted radiopharmaceutical may improve outcomes for ...